Global Cyclospora Diagnostic Testing Market Research Report 2024(Status and Outlook)
The global Cyclospora Diagnostic Testing market size was valued at US$ 156.8 million in 2024 and is projected to reach US$ 238.4 million by 2030, at a CAGR of 7.2% during the forecast period 2024-2030.
The United States Cyclospora Diagnostic Testing market size was valued at US$ 52.3 million in 2024 and is projected to reach US$ 76.9 million by 2030, at a CAGR of 6.6% during the forecast period 2024-2030.
Cyclospora Diagnostic Testing involves laboratory procedures and methods used to detect and diagnose Cyclospora cayetanensis infections, a parasitic illness that causes watery diarrhea and other gastrointestinal symptoms.
The global Cyclospora Diagnostic Testing market is experiencing moderate growth, driven by increasing incidence of foodborne illnesses, growing international travel and trade, and improving healthcare infrastructure in developing regions. In 2023, global Cyclospora tests performed reached approximately 2.5 million, with North America accounting for 45% of test volume. PCR-based molecular tests remain the most widely used method, representing 55% of tests, followed by microscopy at 30% and immunoassays at 15%. The market saw a boost from several large-scale Cyclospora outbreaks linked to imported produce, leading to a 20% increase in testing volumes in affected regions in 2023. Technological advancements have focused on improving test sensitivity and turnaround time, with new multiplex PCR assays offering up to 98% sensitivity and results in under 4 hours, compared to 24-48 hours for traditional methods. The market is witnessing strong growth in point-of-care Cyclospora tests, increasing at 15% annually, driven by the need for rapid diagnosis in travel medicine and outbreak scenarios. In 2023, new FDA guidelines for testing imported produce led to a 25% increase in preventive Cyclospora testing in the food industry. The industry faces challenges from the seasonal nature of Cyclospora infections and limited awareness in some regions, but increasing globalization of food supply chains continues to drive demand for robust testing methods. Emerging applications in environmental monitoring are showing promise, with Cyclospora testing for water sources and agricultural runoff growing at 18% CAGR, albeit from a small base of 2% market share. Looking ahead, the market is expected to benefit from advancements in genomic epidemiology, with next-generation sequencing-based Cyclospora typing methods for outbreak investigations projected to grow at 22% CAGR through 2030.
Report Overview
Cyclospora cayetanensis, a single-celled coccidian parasitic pathogen, causes intestinal infection resulting in diarrhea. In medical terminology, this diarrheal infection is referred as cyclospora infection (cyclosporiasis).
This report provides a deep insight into the global Cyclospora Diagnostic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cyclospora Diagnostic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cyclospora Diagnostic Testing market in any manner.
Global Cyclospora Diagnostic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher Scientific
Beckman Coulter, Inc
bioMerieux, Inc.
CEPHEID
Diamedix Corporation
Hologic, Inc
Nanogen, Inc.
Ortho Clinical Diagnostics (a Johnson & Johnson company)
DiaSorin S.p.A.
Roche Diagnostics (a division of Hoffmann-La Roche)
Siemens Healthcare
QIAGEN N.V.
Wako Chemicals USA, Inc.
Market Segmentation (by Type)
Acid-fast Staining
Safranin Staining
Market Segmentation (by Application)
Commercial or Private Laboratories
Hospitals
Public Health Labs
Physician Offices
Geographic Segmentation
